To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps were taken during the trial of the Pfizer covid-19 vaccine to test its effect on people with allergies.
Answered on
11 January 2021
The Pfizer/BioNTech vaccine has met the Medicines and Healthcare products Regulatory Agency’s robust standards of safety, quality, and effectiveness, and the safety data from the trials has set out how the COVID-19 vaccine works in different types of people. A robust and proactive safety monitoring strategy for COVID-19 vaccines is in place, which allows for rapid, real-time safety monitoring at population level.
Answered by
Department for Business, Energy and Industrial Strategy
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.